UBS Maintains Neutral on Astera Labs, Lowers Price Target to $290

Benzinga · 9h ago
UBS analyst Natalia Winkler maintains Astera Labs (NASDAQ:ALAB) with a Neutral and lowers the price target from $300 to $290.